Vishal Goyal
6PUBLICATIONS
12CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Feb 25, 2025
Model-Informed Drug Development of a Sustained Release Formulation of Flucytosine in the Treatment of Cryptococcal Meningitis: A Case Study Using Physiologically Based Pharmacokinetic Modeling.Johanna Eriksson, Erik Sjögren, Jean-Yves Gillon
|Sep 18, 2024
Bioavailability of a novel sustained-release pellet formulation of 5-flucytosine in healthy-fed participants for use in patients with cryptococcal meningitis.Nabila Ibnou Zekri Lassout, Vishal Goyal, Edrich Krantz
|Mar 15, 2024
Bioavailability of three novel oral, sustained-release pellets, relative to an immediate-release tablet containing 500 mg flucytosine: A randomized, open-label, crossover study in healthy volunteers.Vishal Goyal, Edrich Krantz, Francois Simon
|Sep 27, 2019
Field effectiveness of new visceral leishmaniasis regimens after 1 year following treatment within public health facilities in Bihar, India.Vishal Goyal, Sakib Burza, Krishna Pandey
|Oct 23, 2018
Field safety and effectiveness of new visceral leishmaniasis treatment regimens within public health facilities in Bihar, India.Vishal Goyal, Raman Mahajan, Krishna Pandey
|May 31, 2017
Safety and efficacy of short course combination regimens with AmBisome, miltefosine and paromomycin for the treatment of visceral leishmaniasis (VL) in Bangladesh.Ridwanur Rahman, Vishal Goyal, Rashidul Haque
Pageof 1
Frequent Collaborators
3 joint publications
Johanna Eriksson
3 joint publications
Henri Caplain
3 joint publications
Jean-Yves Gillon
3 joint publications
Isabela Ribeiro
2 joint publications
Francois Simon
2 joint publications
Anouk Neven
2 joint publications
Stephen Robinson
2 joint publications
Carol Ruffell
2 joint publications
Aljosa Celebic
1 joint publications
Nabila Ibnou Zekri Lassout
